Eton Pharmaceuticals

"Eton is primarily focused on hospital injectable and pediatric oral liquid products. The company’s first commercial product, Biorphen, is the only FDA approved ready-to-use formulation of phenylephrine injection and was launched in December 2019."

"The company has an additional eight products under development, including three that are under review with the FDA."

Latest Eton Pharmaceuticals News & Features